Mesoblast (MESO) Net Income towards Common Stockholders: 2014-2025
Historic Net Income towards Common Stockholders for Mesoblast (MESO) over the last 12 years, with Jun 2025 value amounting to -$102.1 million.
- Mesoblast's Net Income towards Common Stockholders fell 2.34% to -$21.6 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$81.9 million, marking a year-over-year increase of 10.35%. This contributed to the annual value of -$102.1 million for FY2025, which is 16.13% down from last year.
- As of FY2025, Mesoblast's Net Income towards Common Stockholders stood at -$102.1 million, which was down 16.13% from -$88.0 million recorded in FY2024.
- Over the past 5 years, Mesoblast's Net Income towards Common Stockholders peaked at -$81.9 million during FY2023, and registered a low of -$102.1 million during FY2025.
- For the 3-year period, Mesoblast's Net Income towards Common Stockholders averaged around -$90.7 million, with its median value being -$88.0 million (2024).
- Per our database at Business Quant, Mesoblast's Net Income towards Common Stockholders fell by 26.78% in 2021 and then rose by 10.35% in 2023.
- Mesoblast's Net Income towards Common Stockholders (Yearly) stood at -$98.8 million in 2021, then grew by 7.55% to -$91.3 million in 2022, then increased by 10.35% to -$81.9 million in 2023, then decreased by 7.41% to -$88.0 million in 2024, then dropped by 16.13% to -$102.1 million in 2025.